Outcome of percutaneous drainage for septic complications coexisted with COVID-19

Deif, Mohamed A; Mounir, Ahmad M.; Abo-Hedibah, Sherif A.; Khalek, Ahmed M Abdel; Elmokadem, Ali H.

doi:10.4329/wjr.v14.i4.91

Cited by 2 publications

(2 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several reports in the literature have described the presentation of acute cholecystitis in COVID-19 patients, with most of them being case reports and letters to the editor and some case series ( Table 1 ) [ 10 , 19 , 20 , 21 , 22 , 91 , 92 , 94 , 95 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 ].…”

Section: Worldwide Cases Of Aac In Covid-19mentioning

confidence: 99%

“…Several reports in the literature have described the presentation of acute cholecystitis in COVID-19 patients, with most of them being case reports and letters to the editor and some case series (Table 1) [10,[19][20][21][22]91,92,94,95,[100][101][102][103][104][105][106][107][108][109][110][111][112][113][114]. Bruni et al, described the first case of histopathological findings of an acute ischemic gangrenous cholecystitis as a late complication in a COVID-19 [95].…”

Section: Worldwide Cases Of Aac In Covid-19mentioning

confidence: 99%

See 1 more Smart Citation

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review

Thomaidou,

Karlafti,

Didagelos

et al. 2024

Viruses

View full text Add to dashboard Cite

Acute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5–10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread worldwide, leading to an unprecedented pandemic. The virus enters cells through the binding of the spike protein to angiotensin-converting enzyme 2 (ACE2) receptors expressed in many human tissues, including the epithelial cells of the gastrointestinal (GI) tract, and this explains the symptoms emanating from the digestive system. Acute cholecystitis has been reported in patients with COVID-19. The purpose of this review is to provide a detailed analysis of the current literature on the pathogenesis, diagnosis, management, and outcomes of AAC in patients with COVID-19.

show abstract

Section: Worldwide Cases Of Aac In Covid-19mentioning

confidence: 99%

“…Several reports in the literature have described the presentation of acute cholecystitis in COVID-19 patients, with most of them being case reports and letters to the editor and some case series (Table 1) [10,[19][20][21][22]91,92,94,95,[100][101][102][103][104][105][106][107][108][109][110][111][112][113][114]. Bruni et al, described the first case of histopathological findings of an acute ischemic gangrenous cholecystitis as a late complication in a COVID-19 [95].…”

Section: Worldwide Cases Of Aac In Covid-19mentioning

confidence: 99%

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review

Thomaidou,

Karlafti,

Didagelos

et al. 2024

Viruses

View full text Add to dashboard Cite

show abstract

Treatment of Candida albicans liver abscess complicated with COVID-19 after liver metastasis ablation: A case report

Wen¹,

Lin²,

Meng³

et al. 2023

World J Gastrointest Oncol

View full text Add to dashboard Cite

Esophageal cancer (EC) is one of the most common digestive system malignancies in the world. The combined modality treatment of EC is usually surgery and radiation therapy, however, its clinical efficacy for advanced patients is relatively limited. Ferroptosis, a new type of iron-dependent programmed cell death, is different from apoptosis, necrosis and autophagy. In recent years, many studies have further enlightened that ferroptosis plays an essential role in the occurrence, development and metastasis of tumors. Targeting ferroptosis stimulates a new direction for further exploration of oncologic treatment regimens. Furthermore, ferroptosis has a critical role in the immune microenvironment of tumors. This paper reviews the mechanism of ferroptosis and the ferroptosis research progress in the treatment of EC. We further elaborate the interaction between ferroptosis and immunotherapy, and the related mechanisms of ferroptosis participation in the immunotherapy of EC, so as to provide new directions and ideas for the treatment of EC.

show abstract

Outcome of percutaneous drainage for septic complications coexisted with COVID-19

Cited by 2 publications

References 44 publications

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review

Treatment of Candida albicans liver abscess complicated with COVID-19 after liver metastasis ablation: A case report

Contact Info

Product

Resources

About